Urox
Natural health product licensed in Canada
- Other names
- Urox Junior
- Licence holder
- Seipel Group Pty Ltd.
- NPN or DIN-HM
- 80078932
- Status
- Active licence
- Licence date
- 7 July 2017
- Revision date
- 6 May 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lindera aggregata Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 milligramme | 150 milligramme | Not calculated |
| Equisetum arvense Source : Equisetum arvense- Tige Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 milligramme | 150 milligramme | Not calculated |
| Crateva magna Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 3,000 milligramme Potency : 1.5 % lupeol | 120 milligramme | Not calculated |
Non-medicinal ingredients
farine de riz, Hydroxypropyl méthylcellulose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 12 years ; maximum: 13 years | 1 Capsule | 1 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | 1 Capsule | 1 Tous les jours |
| Adolescentes | minimum: 14 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps reduce symptoms of overactive bladder such as daytime urinary frequency, urgency and nocturia (combination of Lindera aggregata, Equisetum arvense and Crateva magna). Helps improve symptoms of urinary incontinence (combinaison of Lindera aggregata, Equisetum arvense, and Crateva magna).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. If you are pregnant or breastfeeding, do not use this product. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of the hands and feet) or are taking diuretics, do not use. Consult a health care practitioner prior to use if you are taking cardiac medications such as cardiac glycosides or antiarrhythmic agents. Stop and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
Source
Official Health Canada record, licence 80078932
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.